Reports
As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.
Global Companion Diagnostics Market: By Product & Service: Assay Kits and Reagents, Software and Services; By Technology: Polymerase Chain Reaction, Immunohistochemistry, Others; By Indication; By End Use; Regional Analysis; Historical Market and Forecast (2016-2026); Competitive Landscape; Industry Events and Developments
Global Companion Diagnostics Market Outlook
The global companion diagnostics market size stood at a value of USD 2.1 billion in 2020. The companion diagnostics market is expected to achieve USD 8.4 billion by 2026, growing at a CAGR of 26% between the forecast period of 2021 and 2026.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The companion diagnostics industry is anticipated to grow significantly during the forecast period due to an increase in R&D of targeted therapies for cancer, along with the increasing demand for personalised medicine.
Properties and Applications
A companion diagnostic is a medical in-vitro device that offers data for the secure and efficient use of a drug and determines its applicability to a specific person. This diagnostic test enables a medical specialist to determine whether a specific therapeutic product helps patients or not, outweighing any severe potential side effects or hazards. The industry can be divided based on its product and services into assay kits and reagents, and software and services.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The industry can be broadly categorised based on its end-use into:
- Pharmaceutical and Biopharmaceutical Companies
- Reference Laboratories
- Other
The industry can be divided based on its technology as polymerase chain reaction, immunohistochemistry, in situ hybridization, and next-generation sequencing, among others.
The industry can be divided based on indication as:
- Oncology
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Melanoma
- Gastric Cancer
- Other Cancers
- Neurology
- Infectious Diseases
- Other Indications
The EMR report looks into the regional companion diagnostics markets like North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Market Analysis
The increased popularity of personalised medicines, rising cases of adverse drug reactions (ADRs) and higher number of unmet needs for treating cancer are the driving factors, accelerating the growth of the companion diagnostics market. An increase in healthcare expenditure, globally, and technological advancements in diagnostic techniques are propelling the positive growth of the industry. With rising awareness, particularly in developing economies, along with the discovery of new biomarkers for diverse conditions, the industry is witnessing a further growth. The growth of the companion animal diagnostics market will also propel the growth of the overall companion diagnostics industry. The cases of cancer is expected drive the growth of the companion diagnostics industry in the oncology segment. The approval of companion diagnostics by government agencies like the FDA is expected to drive the growth of the industry. Unfavourable reimbursement policies in some countries may affect the companion diagnostics market growth during the forecast period.
Competitive Landscape
The report presents a detailed analysis of the following leading companies in the global companion diagnostics market, looking into their capacity, competitive landscape, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
- F. Hoffmann-La Roche AG
- Agilent Technologies, Inc.
- Qiagen N.V.
- Thermo Fisher Scientific Inc.
- Abbott Laboratories, Inc.
- Biomérieux SA
- Danaher Corporation
- Illumina, Inc.
- Myriad Genetics, Inc
- Others
The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2020 |
| Historical Period | 2016-2020 |
| Forecast Period | 2021-2026 |
| Scope of the Report | Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Product & Service, Technology, Indication, End Use, Region |
| Breakup by Product & Service | Assay Kits and Reagents, Software and Services |
| Breakup by Technology | Polymerase Chain Reaction, Immunohistochemistry, In Situ Hybridization, Next-Generation Sequencing, Other Technologies |
| Breakup by Indication | Oncology, Neurology |
| Breakup by End Use | Pharmaceutical and Biopharmaceutical Companies, Reference Laboratories, Other End Users |
| Breakup by Region | North America, Europe, Asia Pacific, Latin America, Middle East and Africa |
| Market Dynamics | SWOT, Porter's Five Forces, EMR’s Key Indicators for Price and Demand |
| Competitive Landscape | Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications |
| Companies Covered | F. Hoffmann-La Roche AG, Agilent Technologies, Inc., Qiagen N.V., Thermo Fisher Scientific Inc., Abbott Laboratories, Inc., Biomérieux SA, Danaher Corporation, Illumina, Inc., Myriad Genetics, Inc, Others |
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
Key Questions Answered in the Global Companion Diagnostics Market Report
- How has the global companion diagnostics market performed in the previous years (2016-2020)?
- What is the forecast assessment of the industry for 2021-2026?
- What are the major drivers for the historical (2016-2020) and forecast (2021-2026) periods?
- What are the major constraints for the historical (2016-2020) and forecast (2021-2026) periods?
- What are the major demand indicators of the global industry?
- Who are the key manufacturers in the global companion diagnostics market?
- What is the degree of competition in the global industry?
- What are the major events and developments taking place within the industry globally?
*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.
1 Preface
1.1 Objectives of the Study
1.1.1 Research Objective
1.1.2 Key Findings of the Report
2 Research Methodology
2.1 Data Extraction
2.2 Data Corroboration
2.3 Market Structure
2.4 Assumptions
2.5 Market Models
3 Introduction
3.1 Market Outlook
3.2 Market Scope and Segmentation
3.3 Additional Insights
4 Executive Summary
4.1 Key Market Developments
4.2 Market Analysis
4.3 Key Players
4.4 Cost Structure
4.5 Market Revenue and Growth
5 Market Dynamics
5.1 Market Driver Analysis
5.2 Market Restraint Analysis
5.3 Industry Challenges
5.4 Industry Opportunities
6 Global Companion Diagnostics Market Analysis
6.1 Global Companion Diagnostics Market (2016-2020) & Forecast (2021-2026)
6.2 Global Companion Diagnostics Market Breakup by Product & Service
6.2.1 Assay Kits and Reagents
6.2.2 Software and Services
6.3 Global Companion Diagnostics Market Breakup by Product & Service: Historical Market (2016-2020) & Forecast (2021-2026)
6.3.1 Assay Kits and Reagents
6.3.2 Software and Services
6.4 Global Companion Diagnostics Market by Technology
6.4.1 Polymerase Chain Reaction
6.4.2 Immunohistochemistry
6.4.3 In Situ Hybridization
6.4.4 Next-Generation Sequencing
6.4.5 Other Technologies
6.5 Global Companion Diagnostics Market by Technology: Historical Market (2016-2020) & Forecast (2021-2026)
6.5.1 Polymerase Chain Reaction
6.5.2 Immunohistochemistry
6.5.3 In Situ Hybridization
6.5.4 Next-Generation Sequencing
6.5.5 Other Technologies
6.6 Global Companion Diagnostics Market by Indication
6.6.1 Oncology
6.6.1.1 Breast Cancer
6.6.1.2 Lung Cancer
6.6.1.3 Colorectal Cancer
6.6.1.4 Melanoma
6.6.1.5 Gastric Cancer
6.6.1.6 Other Cancers
6.6.2 Neurology
6.6.2.1 Infectious Diseases
6.6.2.2 Other Indications
6.7 Global Companion Diagnostics Market by Indication: Historical Market (2016-2020) & Forecast (2021-2026)
6.7.1 Oncology
6.7.1.1 Breast Cancer
6.7.1.2 Lung Cancer
6.7.1.3 Colorectal Cancer
6.7.1.4 Melanoma
6.7.1.5 Gastric Cancer
6.7.1.6 Other Cancers
6.7.2 Neurology
6.7.2.1 Infectious Diseases
6.7.2.2 Other Indications
6.8 Global Companion Diagnostics Market by End Use
6.8.1 Pharmaceutical and Biopharmaceutical Companies
6.8.2 Reference Laboratories
6.8.3 Other End Users
6.9 Global Companion Diagnostics Market by End Use: Historical Market (2016-2020) & Forecast (2021-2026)
6.9.1 Pharmaceutical and Biopharmaceutical Companies
6.9.2 Reference Laboratories
6.9.3 Other End Users
6.10 Global Companion Diagnostics Market Breakup by Region
6.10.1 North America
6.10.1.1 United States of America
6.10.1.2 Canada
6.10.2 Europe
6.10.2.1 Germany
6.10.2.2 United Kingdom
6.10.2.3 France
6.10.2.4 Italy
6.10.2.5 Others
6.10.3 Asia Pacific
6.10.3.1 China
6.10.3.2 Japan
6.10.3.3 India
6.10.3.4 ASEAN
6.10.3.5 Others
6.10.4 Latin America
6.10.4.1 Brazil
6.10.4.2 Argentina
6.10.4.3 Mexico
6.10.4.4 Others
6.10.5 Middle East & Africa
6.10.5.1 Saudi Arabia
6.10.5.2 United Arab Emirates
6.10.5.3 Nigeria
6.10.5.4 South Africa
6.10.5.5 Others
6.11 Global Companion Diagnostics Market Breakup by Region: Historical Market (2016-2020) & Forecast (2021-2026)
6.11.1 North America
6.11.1.1 United States of America
6.11.1.2 Canada
6.11.2 Europe
6.11.2.1 Germany
6.11.2.2 United Kingdom
6.11.2.3 France
6.11.2.4 Italy
6.11.2.5 Others
6.11.3 Asia Pacific
6.11.3.1 China
6.11.3.2 Japan
6.11.3.3 India
6.11.3.4 ASEAN
6.11.3.5 Others
6.11.4 Latin America
6.11.4.1 Brazil
6.11.4.2 Argentina
6.11.4.3 Mexico
6.11.4.4 Others
6.11.5 Middle East & Africa
6.11.5.1 Saudi Arabia
6.11.5.2 United Arab Emirates
6.11.5.3 Nigeria
6.11.5.4 South Africa
6.11.5.5 Others
7 SWOT Analysis
7.1 Overview
7.2 Strengths
7.3 Weaknesses
7.4 Opportunities
7.5 Threats
8 Porter’s Five Forces Analysis
8.1 Overview
8.2 Buyer’s Power
8.3 Supplier’s Power
8.4 New Entrants
8.5 Degree of Rivalry
8.6 Substitutes
9 Competitive Landscape & Supplier Analysis
9.1 F. Hoffmann-La Roche AG
9.1.1 Company Overview
9.1.2 Financial Analysis
9.2 Agilent Technologies, Inc.
9.2.1 Company Overview
9.2.2 Financial Analysis
9.3 Qiagen N.V.
9.3.1 Company Overview
9.3.2 Financial Analysis
9.4 Thermo Fisher Scientific Inc.
9.4.1 Company Overview
9.4.2 Financial Analysis
9.5 Abbott Laboratories, Inc.
9.5.1 Company Overview
9.5.2 Financial Analysis
9.6 Biomérieux SA
9.6.1 Company Overview
9.6.2 Financial Analysis
9.7 Danaher Corporation
9.7.1 Company Overview
9.7.2 Financial Analysis
9.8 Illumina, Inc.
9.8.1 Company Overview
9.8.2 Financial Analysis
9.9 Myriad Genetics, Inc
9.9.1 Company Overview
9.9.2 Financial Analysis
9.10 Others
10 Industry Events and Developments
Purchase Options
Call us on
Purchase Full Report
Mini Report
$1499
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateSingle User License
$2699-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateFive User License
$3699-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$4699-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Contact AnalystAny Question? Speak With An Analyst
Request SampleView A Sample
Request CustomisationDid You Miss Anything, Ask Now
Why Expert Market Research?RIGHT PEOPLE
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
RIGHT METHODOLOGY
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
RIGHT PRICE
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
RIGHT SUPPORT
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
Similar Reports
The global liquid biopsy market stood at a value of around USD 1,250 million in 2020. The market is further expected to grow at a CAGR of 22% in the forecast period of 2021-2026 to attain a value of U...
The global mammography market attained a value of USD 1.85 billion in 2020, driven by the rising healthcare expenditures, a thriving healthcare market, and the demand for routine screening.
The North America COVID-19 diagnostics market is primarily being driven by the high number of COVID-19 positive cases, especially in the United States of America, which performed about 390 million tes...
The global COVID-19 diagnostics market is being aided by the growing cases of COVID-19 infections in the United States of America, which had performed about 390 million tests for COVID-19 as of March ...
The Asia Pacific COVID-19 diagnostics market is being aided by the growing cases of COVID-19 infections in India and China, which have performed around 234 million and 160 million tests, respectively,...
NEWSLETTER